• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

    7.900 -0.280 (-3.42%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,789,431
    Open 7.930
    Bid (Size) 7.870 (2)
    Ask (Size) 7.950 (5)
    Prev. Close 8.180
    Today's Range 7.720 - 8.280
    52wk Range 3.520 - 23.40
    Shares Outstanding 45,676,887
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Levi & Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPR
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Fraud Lawsuit
    Levi & Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPR
    Via TheNewswire.com
    Topics Fraud Lawsuit

    Performance

    YTD
    -47.2%
    -47.2%
    1 Month
    -18.6%
    -18.6%
    3 Month
    -38.0%
    -38.0%
    6 Month
    -48.0%
    -48.0%
    1 Year
    +94.6%
    +94.6%

    More News

    Read More
    SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
    From Pomerantz LLP
    Via GlobeNewswire
    Contact Levi & Korsinsky by September 15, 2025 Deadline to Join Class Action Against Capricor Therapeutics, Inc. (CAPR)
    Via NewMediaWire
    Topics Fraud Lawsuit
    Contact Levi & Korsinsky by September 15, 2025 Deadline to Join Class Action Against Capricor Therapeutics, Inc. (CAPR)
    Via TheNewswire.com
    Topics Fraud Lawsuit
    REPL Stock Nearly Doubled In Value Today: What's Going On?
    Via Stocktwits
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?
    Via Benzinga
    Capricor Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CAPR
    Via NewMediaWire
    Topics Fraud Lawsuit
    Capricor Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CAPR
    Via TheNewswire.com
    Topics Fraud Lawsuit
    These stocks are moving in today's pre-market session
    Via Chartmill
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why LendingClub Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    CAPR LAWSUIT ALERT: Levi & Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
    Via NewMediaWire
    Topics Fraud Lawsuit
    CAPR LAWSUIT ALERT: Levi & Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
    Via TheNewswire.com
    Topics Fraud Lawsuit
    Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits
    From Bragar Eagel & Squire
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
    From Pomerantz LLP
    Via GlobeNewswire
    Investors in Capricor Therapeutics, Inc. Should Contact Levi & Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPR
    Via NewMediaWire
    Topics Fraud Lawsuit
    Investors in Capricor Therapeutics, Inc. Should Contact Levi & Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPR
    Via TheNewswire.com
    Topics Fraud Lawsuit
    SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR)
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    CAPR Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Capricor Therapeutics, Inc. Securities Class Action
    From Robbins LLP
    Via GlobeNewswire
    INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    September 15, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CAPR
    Via NewMediaWire
    Topics Fraud Lawsuit
    September 15, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CAPR
    Via TheNewswire.com
    Topics Fraud Lawsuit

    Frequently Asked Questions

    Is Capricor Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Capricor Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Capricor Therapeutics, Inc. - Common Stock trade on?
    Capricor Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Capricor Therapeutics, Inc. - Common Stock?
    The ticker symbol for Capricor Therapeutics, Inc. - Common Stock is CAPR on the Nasdaq Stock Market
    What is the current price of Capricor Therapeutics, Inc. - Common Stock?
    The current price of Capricor Therapeutics, Inc. - Common Stock is 7.900
    When was Capricor Therapeutics, Inc. - Common Stock last traded?
    The last trade of Capricor Therapeutics, Inc. - Common Stock was at 08/01/25 04:00 PM ET
    What is the market capitalization of Capricor Therapeutics, Inc. - Common Stock?
    The market capitalization of Capricor Therapeutics, Inc. - Common Stock is 360.85M
    How many shares of Capricor Therapeutics, Inc. - Common Stock are outstanding?
    Capricor Therapeutics, Inc. - Common Stock has 361M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.